How We Collaborate

We build strategic partnerships with educational institutes, industry, investors, entrepreneurs, and philanthropists who share our vision of making breakthrough scientific discoveries accessible for commercial purposes.
Contact uS

Industry

We work closely with industry in bridging their R&D gaps as well as providing them access to state-of-the-art technology and helping them become technology leaders in their sectors. For several years, WRCB has successfully operated the Industry Research Partnership Program (IRPP) which has fostered close relationships between industry and IITB faculty resulting in fruitful collaborations.

Alliance with Northpond Labs

Our alliance with Northpond Labs supports early-stage, transformative research with strong translational potential as part of a collaborative Laboratory for Bioengineering Research Innovation.

Investors

WRCB has successfully enabled the translation of several deep technologies into spin-off companies. We work closely with angel investors, early-stage biotech VCs and strategic investors to facilitate access to follow-on capital for our entrepreneurs. If you are any of the above, we invite you to become an investment partner and receive information about our spin-off companies and access early investment opportunities.

Brain Targeting Program

Pre-competitive multi-partner industry collaboration that aims to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain.

Entrepreneurs

For entrepreneurs with access to capital and looking for promising bioengineering technologies spanning affordable diagnostics, MedTech, therapeutics, and synthetic biology, WRCB facilitates access to technologies and technical co-founders for potential spin-off partnerships. You can also explore licensing opportunities through IIT Bombay’s Industrial Research and Consultancy Centre (IRCC) if you wish to take any WRCB-funded technology to market.

Fast creation of diagnostic technologies

An initiative to enable the fast creation of diagnostic technologies to solve high-value clinical problems through deep collaborations driven by unmet diagnostic needs.

Cancer immunologists

Cancer immunologists and biological engineers are developing new biomaterials-based approaches to develop new anti-cancer immunotherapies for treatment-resistant cancers.

CSR

Almost all WRCB projects are CSR-relevant. Our projects cover affordable healthcare, sustainability, biomanufacturing, carbon capture and other related areas. We welcome CSR contributions to our projects. You can review the brief’s of our CSR projects below

CSR Project Listing

Pre-competitive multi-partner industry collaboration that aims to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain.

Philanthropists

WRCB accepts co-funding of its research and commercialization activities via private donations through the office of the Dean (Alumni and Corporate Relations). Our work has led to several IPs, publications, and spin-off companies. We are confident that we can scale our impact with additional donations by funding more projects and funding them more deeply. Your donation can help us make a more significant impact in translating bioengineering research.

Back to Top
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram